trending Market Intelligence /marketintelligence/en/news-insights/trending/tpieum-cuka6cp33pcnfkq2 content esgSubNav
In This List

PolarityTE adds former US FDA, Johnson & Johnson executive as director

Blog

Funding Social and Affordable Housing: A Credit Perspective

Blog

Global M&A By the Numbers: Q2 2021

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times


PolarityTE adds former US FDA, Johnson & Johnson executive as director

PolarityTE Inc. has appointed Minnie Baylor-Henry to the board.

Previously, Baylor-Henry was a regulatory review officer, among other positions, at the U.S. Food and Drug Administration's Office of Regulatory Affairs. She was also vice president of U.S. regulatory affairs and medical affairs for specialty pharmaceuticals at Johnson & Johnson.

Salt Lake City-based PolarityTE is a biotechnology and regenerative biomaterials company.